Return to top of page

Testimony

Alliance Urges CMS to Consider Biosimilar Alternatives in Drug Selection

January 27, 2026

Testimony before Energy and Commerce Committee, Subcommittee on Health, on Examining FDA’s Medical Device User Fee Program

March 27, 2017

Alliance President Makes Remarks at a Hearing on Prescription Drug User Fee Act Reauthorization

April 1, 2010

Fiscal Year 2008 Appropriations for the National Institute on Aging: U.S. Senate, Subcommittee on Labor, Health and Human Services, Education and Related Agencies

March 30, 2007

Fiscal Year 2007 Appropriations for the National Institute on Aging: U.S. Senate, Subcommittee on Labor Health and Human Services, Education and Related Agencies

April 28, 2006

Ageism in Healthcare Testimony: Senate Special Committee on Aging

May 19, 2003

Stem Cell Testimony: National bioethics advisory commission

January 19, 1999